N-Acetyl Semax Amidate

NASA is Semax with both ends chemically armored — N-terminal acetyl group blocks aminopeptidase, C-terminal amide blocks carboxypeptidase — yielding (claimed) longer duration and (claimed) 3-5x potency vs regular Semax. Real evidence is thin: parent-compound mechanism extrapolation + anecdotes + vendor marketing. For Dylan, it's a quality-of-life upgrade over regular Semax IF you can verify what's in the bottle; otherwise stick with CosmicNootropic regular Semax which has a real Russian pharma supply chain.

NASA is a structurally modified Semax. The base sequence is the same heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro), but two chemical groups are added:

1. N-terminal acetylation — an acetyl group caps the free amino terminus on Met. The free amino group is what leucine aminopeptidase recognizes to chew off the first amino acid. Cap it, and that enzyme can't bind. This change alone roughly doubles duration of intact peptide in plasma (parent compound studies; see Russian Journal of Bioorganic Chemistry 2011 on aminopeptidase proteolysis of Semax analogs).

2. C-terminal amidation — the free C-terminal carboxyl group on the terminal proline is replaced with an amide (-C(=O)-NH2 instead of -COOH). Carboxypeptidases require a free carboxyl to bind. Cap it, and degradation from the C-end is blocked.

Together: peptidase resistance from both ends, so the intact peptide circulates longer and more reaches CNS via olfactory/trigeminal nose-to-brain transport (intranasal route).

Downstream effects are the same as regular Semax (because the active sequence is unchanged):

• BDNF + TrkB upregulation in hippocampus and PFC (parent compound: ~1.4-1.8x BDNF mRNA increase within 3 hr of intranasal dose; TrkB receptor density also increases)
• NGF upregulation (less consistently demonstrated than BDNF)
• Monoamine modulation — increases dopamine and serotonin tone; reported MAO-B inhibition (mechanism unclear)
• Enkephalinase inhibition — preserves endogenous opioid tone (likely the "mood-positive without euphoria" feel)
• HIF-1α stabilization (noted in some Russian stroke literature as part of neuroprotective response)
• Cerebral blood flow + reduced oxidative stress in ischemia models

On the "D-Lys" naming in the prompt: I could not find published evidence of a mainstream "N-Acetyl-(D-Lys)-Semax-Amidate" variant. The dominant NASA structure marketed and discussed in research-chem circles is Ac-Met-Glu-His-Phe-Pro-Gly-Pro-NH2 (no D-amino acid substitution). Adding a D-Lys would be a further modification on top of NASA, and while D-amino acid substitutions are a standard peptide-stability technique, I found no specific NASA-with-D-Lys product on vendor catalogs or in published literature. Flagged as accuracy concern — see "Controversies" section. If Dylan has seen a vendor specifically advertising "D-Lys" NASA, that vendor needs extra scrutiny.